Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/1995
12/28/1995WO1995035032A1 SUPPRESSION OF NUCLEAR FACTOR-kB DEPENDENT PROCESSES USING OLIGONUCLEOTIDES
12/28/1995WO1995028487A3 Recombinant pgp3, methods of preparation and use in diagnosis and therapy
12/28/1995WO1995027495A3 Treatment of partial growth hormone insensitivity syndrome
12/28/1995WO1995016051A3 Methods and compositions for the suppression of neu mediated transformation
12/28/1995WO1995014713A3 Abundant extracellular products and methods for their production and use
12/28/1995CA2193530A1 Administration of pirenzepine, methyl scopolamine and other muscarinic receptor antagonists for treatment of lipid metabolism disorders
12/28/1995CA2193526A1 Polypeptides with interleukin 8 receptor 1 (il8r1) binding domains
12/28/1995CA2193362A1 Modulators of pneumococcal adhesion to cellular targets involving the platelet activating factor receptor, and uses thereof
12/28/1995CA2193206A1 Contraceptive vaccine
12/28/1995CA2193205A1 High-affinity melatonin receptors and uses thereof
12/28/1995CA2193133A1 Novel thrombin inhibitors, the preparation and use thereof
12/28/1995CA2192827A1 Use of .beta.galnac(1-4).beta.gal conjugates to treat candida infection
12/28/1995CA2192697A1 Methods of synthesis of peptidyl argininals
12/28/1995CA2192686A1 Arginine mimic derivatives as enzyme inhibitors
12/28/1995CA2192484A1 New opioid peptide antagonists
12/28/1995CA2192211A1 3-amino-2-oxo-1-piperidineacetic derivatives containing an arginine mimic as enzyme inhibitors
12/28/1995CA2192210A1 3-amino-2-oxo-1-piperidineacetic derivatives as enzyme inhibitors
12/28/1995CA2165956A1 Novel substituted purinyl derivatives with immunomodulating activity
12/27/1995EP0689052A2 Insulin standard solution
12/27/1995EP0688869A1 Novel osteoinductive compositions
12/27/1995EP0688866A1 Thermostable trehalose-releasing enzyme, and its preparation and uses
12/27/1995EP0688789A1 Lipopeptid-derivatives, process for their preparation and their use
12/27/1995EP0688788A1 Boronic acid peptide derivatives having protease inhibiting activity, process for preparation thereof and pharmaceutical compositions comprising them
12/27/1995EP0688365A1 Fertility regulation with transforming growth factor beta
12/27/1995EP0688362A1 Cloning and recombinant production of vespid venom enzymes, such as phospholipase and hyaluronidase, and immunological therapies based thereon
12/27/1995EP0688360A1 Bone stimulating factor
12/27/1995EP0688338A1 T cell epitopes of ryegrass pollen allergen
12/27/1995EP0688337A1 Compositions and methods for the treatment of immunomediated inflammatory disorders
12/27/1995EP0688334A1 Oligodendroglial trophic factor and methods of use thereof
12/27/1995EP0688327A1 Analogs for specific oligosaccharide-protein interactions and uses therefor
12/27/1995EP0688315A1 New heterocyclic compounds, their preparation and their use
12/27/1995EP0688314A1 Prodrug derivatives of enzyme inhibitors with hydroxyl groups, methods of preparing them and their use
12/27/1995EP0688229A1 Use of low density lipoprotein with cytotoxic substances
12/27/1995EP0688226A1 Protein preparation for the prevention and therapy of periodontitis or other bacterial pathologies of the oral cavity
12/27/1995EP0688225A1 Methods and compositions for the inhibition of complement activation
12/27/1995EP0688224A1 A mutant protein and methods and materials for making and using it
12/27/1995EP0688211A1 Methods and compositions for inhibition of angiogenesis
12/27/1995EP0688210A1 Use of carnosine or a combination with urocanic acid for treatment of photodermatoses
12/27/1995EP0688209A1 Glycosylation of lipids and lipid-containing particles, and diagnostic and therapeutic methods and materials derived therefrom
12/27/1995EP0688168A1 Method of treating immature birds with il-2
12/27/1995EP0580694A4 Production of phosphopeptides from casein
12/27/1995EP0578726B1 Virus inactivation method
12/27/1995EP0573491A4 Mineralized collagen
12/27/1995EP0550650B1 Antagonists of human gamma interferon
12/27/1995EP0502198B1 Novel polypeptide and anti-hiv drug prepared therefrom
12/27/1995EP0419621B1 Process for the specific replacement of a copy of a gene present in the receiver genome via the integration of a gene
12/27/1995EP0418230B1 Method for potentiating and inhibiting insulin-like growth factor activity
12/27/1995EP0379549B1 Endotoxin binding protein and uses thereof
12/27/1995EP0268663B1 Phosphopeptides
12/27/1995CN1114112A Bacteriocins from streptococcus thermophilus
12/26/1995US5478925 Peptides which block the binding of Tumor Necrosis Factor to its receptors
12/26/1995US5478820 Antibiotic compounds
12/26/1995US5478819 Treating helico bacter infection with synergistic mixture of antibiotic and phsophatide
12/26/1995US5478811 Orally-active elastase inhibitors
12/26/1995US5478810 Peptide amides, processes for the preparation thereof and agents containing these as fibrin/thrombin clotting inhibitors
12/26/1995US5478809 Blood disorders
12/26/1995US5478808 2-amino-6,7-dihydroxy-4-thiaheptanoic acid derivatives, production and use thereof
12/26/1995US5478807 Increases rate of stimulus provided by subsidiary pacemakers
12/26/1995US5478806 Enhancement of antitumor therapy with hemoglobin-based conjugates
12/26/1995US5478805 Fractionation of polyalkylene oxide-conjugated hemoglobin solutions
12/26/1995US5478741 Antibodies to the HRPII protein of plasmodium falciparum
12/26/1995US5478740 Hybridomas and monoclonal antibodies which specifically bind human basic fibroblast growth factor
12/26/1995US5478727 Methods and compositions for the preparation and use of a herpes protease
12/26/1995US5478725 Contacting endometrium sample with monoclonal antibody specific for integrin, assaying, correlating absence with endometriosis
12/26/1995US5478560 External dermatological composition
12/26/1995US5478558 Administering composition free of serum amyloid P, thrombin activity, infectious agents, antibodies
12/26/1995CA1337841C Antibiotic a 42867 derivative
12/26/1995CA1337840C Amides of teicoplanin compounds
12/26/1995CA1337838C Aglycons of a/16686 antibiotics
12/26/1995CA1337796C Plasminogen activator-heparin conjugates
12/25/1995CA2126702A1 Indole-containing peptide and process for preparing the same
12/23/1995CA2152205A1 Boronic acid peptidic derivatives; process for preparing the same and pharmaceutical compositions containing them
12/22/1995WO1994028924A1 Combination of angiotensin converting enzyme inhibitors and aii antagonists
12/22/1995CA2165410A1 Combination of angiotensin converting enzyme inhibitors and all antagonists
12/21/1995WO1995034679A2 Defects in drug metabolism
12/21/1995WO1995034671A1 Complementary adenoviral vector systems and cell lines
12/21/1995WO1995034669A2 Retroviral gene therapy vectors and therapeutic methods based thereon
12/21/1995WO1995034661A1 Fas associated proteins
12/21/1995WO1995034659A1 Manipulation of protoporphyrinogen oxidase enzyme activity in eukaryotic organisms
12/21/1995WO1995034653A1 Epil/placentine
12/21/1995WO1995034652A1 Calcium binding recombinant antibody against protein c
12/21/1995WO1995034651A2 Corticotropin-releasing factor2 receptors
12/21/1995WO1995034650A2 Mn gene and protein
12/21/1995WO1995034649A2 Polycystic kidney disease 1 gene and uses thereof
12/21/1995WO1995034582A1 Bioadhesive starches and process for their preparation
12/21/1995WO1995034581A1 Inhibition of human xenogenic or allogenic antibodies to reduce xenograft or allograft rejection in human recipients
12/21/1995WO1995034579A1 Recombinant molecules, proteins/polypeptides, host systems and diagnostic and therapeutic methods for atopy
12/21/1995WO1995034578A1 Recombinant allergen, fragments thereof, corresponding recombinant dna molecules, vectors and hosts containing the dna molecules, diagnostic and therapeutic uses of said allergens and fragments
12/21/1995WO1995034576A1 A 24 kilodalton cytoplasmic protease activating dna fragmentation apoptosis
12/21/1995WO1995034573A1 Identification of polycystic kidney disease gene, diagnostics and treatment
12/21/1995WO1995034572A1 THE PRODUCTION OF HEMOGLOBIN HAVING A δ-LIKE GLOBIN
12/21/1995WO1995034571A2 Drug salts
12/21/1995WO1995034558A1 Chondramides, production methods, compositions comprising chondramides and cultures for chondramide production
12/21/1995WO1995034326A1 Pegylation reagents and compounds formed therewith
12/21/1995WO1995034324A1 Cross-reacting monoclonal antibodies specific for e-selectin and p-selectin
12/21/1995WO1995034321A1 Immune modulation with class ii alpha-chain fragments
12/21/1995WO1995034320A2 Methods for inhibiting antigen specific t cell responses
12/21/1995WO1995034319A1 Compositions and methods for the treatment of tumors
12/21/1995WO1995034318A1 Solution comprising igf-i or any functional analogue thereof and method for its preparation
12/21/1995WO1995034316A1 Suppression of tumor cell growth by syndecan-1 ectodomain
1 ... 2811 2812 2813 2814 2815 2816 2817 2818 2819 2820 2821 2822 2823 2824 2825 2826 2827 2828 2829 2830 2831 ... 3163